Abstract
The inhibition of gastric secretion has been a therapeutic objective for decades. A variety of pharmacologic and non-pharmacologic approaches have been proposed throughout history. Among the non-pharmacologic proposals, gastric surgery was widely used until effective drugs were available. Initially antacids and later anti-cholinergics, H2 blockers and proton pump inhibitors took the predominant position. Finally, Helicobacter pylori eradication has been the milestone for the cure of peptic ulcers.
Similar content being viewed by others
References
Cheli R. Gastric secretion. New York: Raven Press, 1986
Díaz-Rubio M. Historia de la úlcera. Madrid: You and Us, 1987
Pajares García JM, Pajares Villarroya R, Gisbert JP. Úlcera péptica: cambios conceptuales y manejo clínico en 85 años (1918–2003). Rev Esp Enf Diges 2003; 95 (Suppl.): 31–47
Winkelstein A. Peptic esophagitis: New clinical entity. J Am Med Ass 1935; 104: 906–9
Rey E, Díaz-Rubio M. Enfermedad por reflujo gastroesofágico: un siglo de historia. Rev Esp Enf Diges 2003; 95 (Special Issue): 18–24
Barrett NR. Chronic peptic ulcer of the esophagus and “esophagitis”. Brit J Surg 38; 150: 175–82
Allison PR. Reflux esophagitis, sliding hiatal hernia and the anatomy of repair. Surg Gynecol Obstet 1951; 92: 419–31
Díaz-Rubio M. Uso de los antiácidos en gastroenterología. In: Díaz-Rubio M, editor. Antiácidos en los 80. Madrid: P & B Editors, 1987
Solís Herruzo JA, Díaz-Rubio García M. Nuestra experiencia con la cápsula de Heidelberg en la exploración de la función secretora gástrica. Rev Esp Enf Diges 1970; 30 (Pt 2): 157–78
Díaz-Rubio M. Reflujo gastroesofágico. ¿Una enfermedad esofágica o gástrica? Anal Acad Nac Med 1998; 115: 759–80
García Albarrán J, Ruíz de León A, Fernández Remis E, et al. Reflujo gastroesofágico. Valoración del tratamiento con ranitidina mediante monitorización continua de pH ambulatoria. In: Díaz-Rubio M, editor. Avances en gastroenterología, vol. 4. Madrid: ARAN, 1987; pp. 43–50
Ruíz de León A, Sevilla C, Pérez de la Serna J, et al. Simultaneous two-level esophageal 24-hour pH monitoring in patients with mild and severe esophagitis. Does probe position influence results of esophageal monitoring? Dig Dis Sci 1995; 40: 1423–7
Black JW, Duncan WAM, Durant GJ, et al. Definition and antagonism of histamine H2 receptors. Nature 1972; 236: 385–90
Dobrilla G. Antagonisti dei recettori H2 dell’istamina. Verona: Cortina International, 1986
Díaz-Rubio M. Obstacles to maintenance therapy in peptic ulcer. Res Clin Forums 1988; 10: 63–9
Díaz-Rubio M. Tratamiento preventivo de las recidivas ulcerosas. In: Díaz-Rubio M, editor. Enfermedad ulcerosa péptica. Madrid: ENE, 1987; 131–40
Taxonera Samsó C, Díaz-Rubio M. El problema de los pacientes resistentes. In: Díaz-Rubio M, editor. Enfermedad ulcerosa péptica. Madrid: ENE, 1987; 149–58
Ganser AL, Forte JG. K+-stimulated ATPase in purified microsomes of bullfrog oxyntic cells. Biochem Biophys Acta 1973; 307: 169–80
Modlin IM. From Prout to the proton pump. Konstanz: Schnetztor-Verlag GmbH, 1995
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Díaz-Rubio, M. Historical Perspective of Gastric Acid Inhibition. Drugs 65 (Suppl 1), 1–6 (2005). https://doi.org/10.2165/00003495-200565001-00002
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-200565001-00002